These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6932980)

  • 1. Hormonal effects on cell proliferation in a human erythroleukemia cell line (K562).
    Gauwerky C; Golde DW
    Blood; 1980 Nov; 56(5):886-91. PubMed ID: 6932980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2 receptor-mediated stimulation of Friend erythroleukemia cell growth by thyroid hormones.
    Gauwerky CE; Bersch NL; Golde DW
    Exp Hematol; 1981 Sep; 9(8):821-8. PubMed ID: 6276212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone polypeptides stimulate proliferation of K562 human erythroleukemia cells.
    Gauwerky C; Golde DW; Li CH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1208-10. PubMed ID: 6448265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of progesterone P1-1 on glutathione-s-transferase and its antiproliferative effect on human erythroleukemia K562 cells].
    Kalinina EV; Novichkova MD; Shcherbak NP; Saprin AN
    Vopr Onkol; 2000; 46(1):68-73. PubMed ID: 10789228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K562 cells produce and respond to human erythroid-potentiating activity.
    Avalos BR; Kaufman SE; Tomonaga M; Williams RE; Golde DW; Gasson JC
    Blood; 1988 Jun; 71(6):1720-5. PubMed ID: 2836003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of thyroid hormones on in vitro erythropoiesis. Mediation by a receptor with beta adrenergic properties.
    Popovic WJ; Brown JE; Adamson JW
    J Clin Invest; 1977 Oct; 60(4):907-13. PubMed ID: 19501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions.
    Yamamoto Y; Shiraishi M; Fujita M; Kojima I; Tanaka Y; Tachibana S
    Mol Cell Biochem; 2014 Jun; 391(1-2):217-24. PubMed ID: 24604674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone modulation of murine erythroleukemia cell growth in vitro.
    Golde DW; Bersch N; Li CH
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3437-9. PubMed ID: 277946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the Na+,K(+)-ATPase activity of K562 human erythroleukemia cells by triiodothyronine.
    Arumanayagam M; Swaminathan R
    Life Sci; 1992; 51(25):1913-20. PubMed ID: 1333560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man.
    Mladenovic J; Adamson JW
    Br J Haematol; 1984 Feb; 56(2):323-32. PubMed ID: 6691924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukemia cell line K562 responds to erythroid-potentiating activity.
    Gauwerky CE; Lusis AJ; Golde DW
    Blood; 1982 Feb; 59(2):300-5. PubMed ID: 6976809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory role of the adrenergic agonists phenylephrine and isoproterenol on fetal hemoglobin expression and erythroid differentiation.
    Mei Y; Yin N; Jin X; He J; Yin Z
    Endocrinology; 2013 Dec; 154(12):4640-9. PubMed ID: 24080366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.
    Murray NR; Baumgardner GP; Burns DJ; Fields AP
    J Biol Chem; 1993 Jul; 268(21):15847-53. PubMed ID: 8340409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A.
    Santoro MG; Crisari A; Benedetto A; Amici C
    Cancer Res; 1986 Dec; 46(12 Pt 1):6073-7. PubMed ID: 2430689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Adrenergic blockade of prostaglandin E2- and D2-induced erythroid colony formation.
    Belegu M; Beckman B; Fisher JW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):C322-7. PubMed ID: 6579847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells.
    Tsiftsoglou AS; Gusella JF; Volloch V; Housman DE
    Cancer Res; 1979 Oct; 39(10):3849-55. PubMed ID: 289436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multihormonal control of cell proliferation: opposite effects of two stimulators (17 beta-estradiol and L-triiodothyronine) and one inhibitor (dexamethasone) on F4Z2 pituitary tumor cells.
    Zhou-Li F; Joly-Pharaboz MO; Bouillard B; Albaladejo V; Nicolas B; Andre J
    Endocrinology; 1991 Jun; 128(6):2761-8. PubMed ID: 2036960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM; Chiou HY; Chang JL
    J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.